ask="44.90"
ask_size="400"
average_daily_volume="1249340"
bid="44.50"
bid_size="500"
book_value="11.83"
change="+4.33"
change_from_200_day_moving_average="-7.53"
change_from_50_day_moving_average="4.72"
change_from_52_week_high="-35.15"
change_From_52_week_low="13.58"
change_in_percent="+10.66%"
close="44.96"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-4.55"
ebitda="-384.49M"
eps_estimate_current_year="-4.93"
eps_estimate_next_quarter="-1.37"
eps_estimate_next_year="-4.65"
ex_dividend_date="N/A"
float_shares="70877000"
high="46.54"
high_52_weeks="80.11"
last_trade_date="2/9/2017"
last_trade_price="44.96"
last_trade_size="80639"
last_trade_time="4:00pm"
low="40.93"
low_52_weeks="31.38"
market_capitalization="3.86B"
moving_average_200_day="52.49"
moving_average_50_day="40.24"
name="Alnylam Pharmaceuticals
Inc."
notes="N/A"
one_year_target_price="64.33"
open="40.93"
pe_ratio="N/A"
peg_ratio="-0.18"
percent_change_from_200_day_moving_average="-14.34%"
percent_change_from_50_day_moving_average="+11.74%"
percent_change_from_52_week_high="-43.88%"
percent_change_from_52_week_low="+43.28%"
previous_close="40.63"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="3.43"
price_per_sales="93.58"
revenue="37.26M"
shares_outstanding="85813000"
short_ratio="8.69"
stock_exchange="NMS"
symbol="ALNY"
volume="2262859"
weeks_range_52="31.38 - 80.11"
